Cellebrite DI

CLBT

Software - Infrastructure · Technology

Exchange

NASDAQ

Winston Score

Winston is curious

A decent business — some strong pillars, some weaker.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Good

Growth

Mixed

Cash Flow

Exceptional

Stability

Exceptional

Valuation

Good

Track this stock — start free trial

Winston Score History

The full picture

Cellebrite makes software and tools that help law enforcement agencies, government investigators, and corporations collect and analyze digital evidence from smartphones, computers, and other devices. Its main product is a platform that can extract data from locked or damaged phones — things like messages, photos, and app activity — to help solve crimes or conduct investigations. The company is one of the leading providers of digital intelligence technology used by police and government agencies around the world.

Cellebrite earns most of its revenue through software subscriptions and licenses, with a smaller portion from hardware sales and professional services. It operates globally, with customers in over 100 countries, though the United States and Israel are its most important markets. The company's deep integration into law enforcement workflows and the technical difficulty of replicating its capabilities give it a meaningful competitive moat, but ongoing legal and ethical scrutiny over how its tools are used — including concerns about misuse by authoritarian governments — remains a key risk to its reputation and growth.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+15.8% YoY

YoY Growth Rate

Steady revenue growth

EPS Growth

-68.3% YoY

YoY Growth Rate

Earnings declining

Insider Activity

50.5%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$546M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth + cash flow

Cellebrite DI is a rare growth stock that's already generating positive cash flow while growing at 16%. The Winston Score doesn't fully credit this transition from "burner" to "earner."

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

80.8%

Premium pricing power — 80.8% gross margin

Profit after running costs

Operating Margin

5.8%

Thin — 5.8% operating margin

Return on the money invested

ROCE

10.4%

Below par — 10.4% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+17.8%

Fast-growing sales (+17.8% YoY)

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

5/8 quarters

Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

260%

Turns 260% of profit into real cash

Spare cash per sale

FCF Margin

27.1%

Converts sales into free cash efficiently (27.1%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.01

Conservative — low debt load (0.01)

Covers its interest

Interest Cover

100.00x

Comfortably covers interest (100.0x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

46.9x

no trend

Expensive — P/E 46.9

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

+21.7

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (46.9 → 25.3)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial